17th Nov 2022: The diabetes disruptor will utilize the fresh shot of fuel to amp-up product, sales, customer experience and teams to the next level.

Well known diabetes-care startup BeatO has raised $33 million in a funding round led by Lightrock. HealthQuad, Flipkart and existing investors including Blume Ventures and Leo Capital were the other participants in the round. 

The company – which makes affordable diabetes care a reality for those who cannot afford specialists for treatment – will be leveraging the fresh round of capital to fine tune product, expand sales footprint pan-India, hire the right talent, amp up customer experience and take the business to the next level. 

The BeatO app is used by customers to track glucose levels and health vitals. The brand’s product portfolio also includes devices that can be connected to a smartphone to collect data. One can also access doctors through online consultations on the platform. 

With more than 200 million citizens at risk of the disease, India is slated to overtake China as the world’s diabetes capital soon. BeatO’s overarching mission is to fix the ‘broken ecosystem’ - a mandate which will include ‘correcting’ the paucity of specialists, particularly in Tier2 cities – to ensure quality and continuous diabetes care to those in need.

BeatO serves over 1.5 million customers currently. As per the company’s claims, the organization has grown 3x over the last year, and is poised to become the leader in its segment and market. 

*This press release is published by VOH team.*

Partners & Associate